Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Venneri

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
European Heart Journal|July 11, 2025
Transthyretin amyloid cardiomyopathy: natural history and treatment response assessed by cardiovascular magnetic resonanceRishi K Patel, Adam Ioannou, Awais Sheikh, et al.
JAMA Cardiology|November 17, 2024
Kidney Outcomes in Transthyretin Amyloid CardiomyopathyAdam Ioannou, Yousuf Razvi, Aldostefano Porcari, et al.
JACC. Cardiovascular Imaging|May 13, 2023
Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume MappingAdam Ioannou, Rishi K Patel, Ana Martinez-Naharro, et al.
Rheumatology (Oxford, England)|May 17, 2024
Native myocardial T1 and right ventricular size by CMR predict outcome in systemic sclerosis-associated pulmonary hypertensionDaniel S Knight, Ruta Virsinskaite, Nina Karia, et al.
JAMA Cardiology|July 19, 2023
Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 MappingAdam Ioannou, Rishi K Patel, Ana Martinez-Naharro, et al.
European Heart Journal. Cardiovascular Imaging|July 1, 2022
Distinct cardiovascular phenotypes are associated with prognosis in systemic sclerosis: a cardiovascular magnetic resonance studyDaniel S Knight, Nina Karia, Alice R Cole, et al.
Blood|January 9, 2024
Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosisJoshua Bomsztyk, Sriram Ravichandran, Hannah V Giles, et al.
European Journal of Heart Failure|December 27, 2022
Sex differences among patients with transthyretin amyloid cardiomyopathy - from diagnosis to prognosisRishi K Patel, Adam Ioannou, Yousuf Razvi, et al.
Journal of the American College of Cardiology|December 10, 2025
Myocardial Amyloid Burden in Transthyretin AmyloidosisAwais Sheikh, Anouk Achten, Alberto Aimo, et al.
European Journal of Heart Failure|October 16, 2025
Artificial intelligence-based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosisLucia Venneri, Alberto Aimo, Aldostefano Porcari, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
European Heart Journal|July 11, 2025
Transthyretin amyloid cardiomyopathy: natural history and treatment response assessed by cardiovascular magnetic resonanceRishi K Patel, Adam Ioannou, Awais Sheikh, et al.
JAMA Cardiology|November 17, 2024
Kidney Outcomes in Transthyretin Amyloid CardiomyopathyAdam Ioannou, Yousuf Razvi, Aldostefano Porcari, et al.
JACC. Cardiovascular Imaging|May 13, 2023
Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume MappingAdam Ioannou, Rishi K Patel, Ana Martinez-Naharro, et al.
Rheumatology (Oxford, England)|May 17, 2024
Native myocardial T1 and right ventricular size by CMR predict outcome in systemic sclerosis-associated pulmonary hypertensionDaniel S Knight, Ruta Virsinskaite, Nina Karia, et al.
JAMA Cardiology|July 19, 2023
Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 MappingAdam Ioannou, Rishi K Patel, Ana Martinez-Naharro, et al.
European Heart Journal. Cardiovascular Imaging|July 1, 2022
Distinct cardiovascular phenotypes are associated with prognosis in systemic sclerosis: a cardiovascular magnetic resonance studyDaniel S Knight, Nina Karia, Alice R Cole, et al.
Blood|January 9, 2024
Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosisJoshua Bomsztyk, Sriram Ravichandran, Hannah V Giles, et al.
European Journal of Heart Failure|December 27, 2022
Sex differences among patients with transthyretin amyloid cardiomyopathy - from diagnosis to prognosisRishi K Patel, Adam Ioannou, Yousuf Razvi, et al.
Journal of the American College of Cardiology|December 10, 2025
Myocardial Amyloid Burden in Transthyretin AmyloidosisAwais Sheikh, Anouk Achten, Alberto Aimo, et al.
European Journal of Heart Failure|October 16, 2025
Artificial intelligence-based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosisLucia Venneri, Alberto Aimo, Aldostefano Porcari, et al.
Pageof 7